数字健康平台Elfie筹集了1200万美元A轮融资，以扩大对所有疾病免费数字疗法的获取途径-动脉网

Elfie raises $12m to expand access to free digital therapeutics for all diseases

CISION 等信源发布 2025-06-25 21:00



可切换为仅中文







NEW YORK

纽约

，

June 25, 2025

2025年6月25日

/PRNewswire/ --

/美通社/ --

Elfie

埃尔菲

, the free digital health super-app that rewards people for taking care of their health, today announced the closing of its

，这款奖励人们关注自身健康的免费数字健康超级应用，今天宣布了其

$12m

1200万美元

Series A funding round. The round was led by White Star Capital with participation from LifeX Ventures and follow-on support from Integra Partners, FEBE Ventures, and Hustle Fund.

A轮融资。本轮融资由White Star Capital领投，LifeX Ventures参与，Integra Partners、FEBE Ventures和Hustle Fund提供后续支持。

Elfie is on a mission to make healthy living easier, and more rewarding, for the millions of people living with chronic conditions and for those who just want to monitor their health. By combining self-monitoring tools, AI-driven coaching, and real-world rewards, Elfie empowers users to stay on track with their treatment plans and build better health habits..

Elfie 致力于为数百万患有慢性疾病的人们，以及那些仅仅希望监测自身健康状况的用户，提供更便捷、更有益的健康生活方案。通过结合自我监测工具、人工智能驱动的辅导以及现实世界的奖励机制，Elfie 赋予用户坚持治疗计划和养成更健康习惯的能力。

Non-communicable diseases account for

非传染性疾病占

over 70% of deaths

超过70%的死亡

globally, and

全球范围内，以及

75% of healthcare spend in the US

美国医疗支出的75%

, creating urgency for scalable, patient-centric solutions that bridge gaps in traditional care models.

，为可扩展的、以患者为中心的解决方案创造了紧迫性，这些解决方案能够弥合传统护理模式中的差距。

It's a privilege to lead a company with such meaningful social impact. Thanks to our strategic partnerships with the pharmaceutical industry, we're able to offer the world's most complete and engaging health app, for free. We believe the only scalable way to fight the global pandemic of non-communicable conditions is to make self-monitoring fun, rewarding, and accessible to all,' .

领导一家具有如此有意义的社会影响力的公司是一种荣幸。得益于我们与制药行业的战略合作伙伴关系，我们能够免费提供全球最完整、最吸引人的健康应用程序。我们相信，抗击全球非传染性疾病流行的唯一可扩展方法是让自我监测变得有趣、有益且人人可及。

said

说

Ofir Ejnes

奥菲尔·艾涅斯

, CEO & co-founder of Elfie.

，Elfie的首席执行官兼联合创始人。

'That's our mission: to encourage everyone, everywhere, to take charge of their health. This funding round marks a significant milestone as we scale our impact through deeper collaborations with insurers and employers.

“我们的使命是：鼓励所有人、在任何地方，掌控自己的健康。这一轮融资标志着一个重要的里程碑，因为我们通过与保险公司和雇主的深入合作来扩大我们的影响力。

Since its launch in 2021, Elfie has grown to over 700,000 users across four continents, helping individuals self-manage chronic illnesses like obesity, IBS, IBD, high blood pressure, high cholesterol, and diabetes. The app's unique approach combining clinically validated interventions with gamification mechanics and behavioral science has driven 30%+ improvement in adherence for key pharmaceutical partners and measurable health improvements among users..

自 2021 年推出以来，Elfie 已在四大洲积累了超过 70 万用户，帮助个人自我管理肥胖、肠易激综合症 (IBS)、炎症性肠病 (IBD)、高血压、高胆固醇和糖尿病等慢性疾病。该应用程序将经过临床验证的干预措施与游戏化机制和行为科学相结合的独特方法，使其关键制药合作伙伴的依从性提高了 30% 以上，并为用户带来了显著的健康改善。

Users are rewarded for completing simple but critical actions such as monitoring health metrics like blood pressure or glucose levels, logging medication, and engaging with educational content. This continuous positive reinforcement encourages sustained participation and leads to better health outcomes over time..

用户因完成简单但关键的操作而获得奖励，例如监测血压或血糖水平等健康指标、记录药物摄入、以及参与教育内容。这种持续的正向激励鼓励了持续的参与，并随着时间的推移带来了更好的健康结果。

Elfie's rapid traction has already led to multimillion-dollar partnerships with global pharma leaders. These partnerships aim to improve treatment adherence for patients with chronic conditions, while generating real-world data to support market access and ongoing research. In parallel, Elfie is also piloting programs with global insurance carriers, aiming to reduce medical claim costs and loss ratios through better health awareness and medication adherence..

Elfie的快速发展已经促使其与全球制药巨头达成了数百万美元的合作。这些合作旨在提高慢性病患者的治疗依从性，同时生成真实世界数据以支持市场准入和持续研究。与此同时，Elfie还与全球保险公司试点项目，通过提升健康意识和药物依从性来降低医疗索赔成本和赔付率。

'Elfie is tapping into three enormous markets, pharma, insurance, and clinical research, at exactly the right time,'

“艾尔菲正在恰当的时机切入制药、保险和临床研究这三大巨大市场，”

said

说

Eric Martineau-Fortin

埃里克·马蒂诺-福特兰

, Managing Partner at White Star Capital.

，白星资本的管理合伙人。

'They've built a scalable, data-driven platform that improves outcomes for patients while creating measurable ROI for partners. We're thrilled to support their next phase of growth.'

“他们建立了一个可扩展的、数据驱动的平台，在改善患者治疗效果的同时为合作伙伴创造了可衡量的投资回报。我们非常高兴能够支持他们的下一阶段增长。”

With this fundraise, Elfie plans to accelerate user acquisition through new pharma and insurance partnerships, expand the team in

通过此次融资，Elfie计划加速通过新的制药和保险合作伙伴关系来获取用户，并扩大团队。

the United States

美国

, adding talent in product, engineering, and go-to-market, and launch Elfie Research, a

，增加产品、工程和市场推广方面的人才，并推出Elfie Research，一个

decentralized

去中心化的

clinical trial platform to generate real-world evidence and support clinical innovation.

临床试验平台，以生成真实世界证据并支持临床创新。

Elfie's app is currently available across 35 countries, with plans to scale to 10 additional countries by the end of 2025. The app is medically approved across multiple regions and remains 100% free for users, with all revenue generated through enterprise partnerships.

Elfie的应用程序目前在35个国家可用，并计划到2025年底扩展到额外10个国家。该应用程序在多个地区获得医学认可，并且对用户保持100%免费，所有收入均通过企业合作产生。

About Elfie

关于Elfie

Elfie is the super-app for better health. Free for all and backed by science, Elfie empowers people to take control of their chronic conditions through smart tracking, personalized coaching, and real rewards. Whether you're managing hypertension, tracking medications, or just trying to build healthier habits, Elfie helps make it stick.

Elfie 是一款促进健康的超级应用。它免费向所有人开放，并以科学为依据，通过智能追踪、个性化辅导和实际奖励，帮助人们掌控自己的慢性疾病。无论你是在管理高血压、追踪药物使用，还是只是想养成更健康的习惯，Elfie 都能助你一臂之力。

It pays to get better..

变得更好是值得的。

Learn more at

了解更多信息，请访问

www.elfie.co

Media Contact

媒体联系人

media@elfie.co

媒体@elfie.co

www.elfie.co

SOURCE Elfie